A study published in ESMO Open evaluated outcomes of second-line chemotherapy combinations for patients with metastatic pancreatic cancer who had failed on first-line treatments.

Read more: https://www.docwirenews.com/docwire-pick/second-line-therapy-outcomes-in-metastatic-pancreatic-cancer/